Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Asset Utilization Ratio (2011 - 2026)

Lemaitre Vascular (LMAT) reported Asset Utilization Ratio of 0.41 for Q1 2026, up 0.77% year-over-year from 0.41 in Q1 2025, and little changed on a QoQ basis from 0.41 in Q4 2025.

Lemaitre Vascular (LMAT) has 16 years of Asset Utilization Ratio data on file, last reported at 0.41 in Q1 2026.

  • Quarterly Asset Utilization Ratio rose 0.77% year-over-year to 0.41 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.41 (up 0.77% YoY) and the FY2025 annual result came in at 0.43, down 12.62% from the prior year.
  • Asset Utilization Ratio was little changed at 0.41 in Q1 2026 per LMAT's latest filing, from 0.41 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.58 in Q3 2024 and bottomed at 0.41 in Q1 2025.
  • The 5-year median for Asset Utilization Ratio is 0.54 (2022), against an average of 0.51.
  • The widest annual swing landed in 2023, when Asset Utilization Ratio increased 7.69%; it then declined 28.82% in 2025.
  • Tracing LMAT's Asset Utilization Ratio over 5 years: stood at 0.53 in 2022, then rose by 7.69% to 0.57 in 2023, then declined by 16.71% to 0.47 in 2024, then dropped by 13.12% to 0.41 in 2025, then increased by 0.08% to 0.41 in 2026.
  • Per Business Quant, the three latest LMAT Asset Utilization Ratio figures stand at 0.41 (Q1 2026), 0.41 (Q4 2025), and 0.41 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.52
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.40
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.64
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.77
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.58
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.33
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.65
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.54
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.75
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn 0.41

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.41
Dec 31, 2025 0.41
Sep 30, 2025 0.41
Jun 30, 2025 0.41
Mar 31, 2025 0.41
Dec 31, 2024 0.47
Sep 30, 2024 0.58
Jun 30, 2024 0.57
Mar 31, 2024 0.57
Dec 31, 2023 0.57
Sep 30, 2023 0.56
Jun 30, 2023 0.55
Mar 31, 2023 0.54
Dec 31, 2022 0.53
Sep 30, 2022 0.53
Jun 30, 2022 0.54
Mar 31, 2022 0.54
Dec 31, 2021 0.53
Sep 30, 2021 0.57
Jun 30, 2021 0.61
Mar 31, 2021 0.54
Dec 31, 2020 0.50
Sep 30, 2020 0.47
Jun 30, 2020 0.52
Mar 31, 2020 0.64
Dec 31, 2019 0.65
Sep 30, 2019 0.69
Jun 30, 2019 0.68
Mar 31, 2019 0.69
Dec 31, 2018 0.71
Sep 30, 2018 0.73
Jun 30, 2018 0.78
Mar 31, 2018 0.80
Dec 31, 2017 0.81
Sep 30, 2017 0.84
Jun 30, 2017 0.88
Mar 31, 2017 0.89
Dec 31, 2016 0.88
Sep 30, 2016 0.88
Jun 30, 2016 0.87
Mar 31, 2016 0.87
Dec 31, 2015 0.88
Sep 30, 2015 0.90
Jun 30, 2015 0.92
Mar 31, 2015 0.91
Dec 31, 2014 0.86
Sep 30, 2014 0.86
Jun 30, 2014 0.91
Mar 31, 2014 0.95
Dec 31, 2013 0.94
Mar 31, 2012 0.96
Dec 31, 2011 0.94
Sep 30, 2011 0.94